trending Market Intelligence /marketintelligence/en/news-insights/trending/KVdiChIt_YgfR2McSqJT-w2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Scynexis falls out of Nasdaq compliance


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

Scynexis falls out of Nasdaq compliance

Scynexis Inc. said the Nasdaq stock market notified the company that it was not in compliance with the exchange's $1 minimum bid price rule.

The stock market said the closing bid price for Scynexis' common stock was below the required $1 per share for 30 consecutive days.

Nasdaq said the company has 180 calendar days, or until June 18, 2019, to regain compliance. If the company does not regain compliance by the deadline, the Jersey City, N.J.-based company may still be eligible for additional time to comply under certain conditions.

Scynexis plans to evaluate available options to address the deficiency and regain compliance with the rule, the company said in a filing.

Scynexis develops and commercializes anti-infectives. Its lead product candidate SCY-078 is an oral and intravenous drug for treating various fungal infections.